Stock Price
166.21
Daily Change
-2.88 -1.70%
Monthly
-4.08%
Yearly
-19.69%
Q1 Forecast
166.29



Peers Price Chg Day Year Date
Cspc Pharmaceutical 10.41 0.63 6.44% 130.31% Feb/10
Avita Medical 1.14 -0.01 -0.44% -59.75% Feb/10
Sh Fosun Pharma 27.10 0.28 1.04% 6.57% Feb/10
Jiangsu Hengrui 58.62 1.17 2.04% 30.62% Feb/10
Zhangzhou Pientzehuang Pharmaceutical 166.21 -2.88 -1.70% -19.69% Feb/10
Kangmei Pharma 1.93 0.01 0.52% -16.45% Feb/10
WuXi AppTec 101.76 3.06 3.10% 76.94% Feb/10
Tectonic Therapeutic 24.83 0.46 1.89% -28.59% Feb/09
Ionis Pharmaceuticals 84.79 -1.71 -1.98% 169.35% Feb/09
IQVIA Holdings 192.67 5.18 2.76% -6.91% Feb/09

Indexes Price Day Year Date
SHANGHAI 50 3085 2.94 0.10% 17.99% Feb/10

Zhangzhou Pientzehuang Pharmaceutical Co Ltd traded at 166.21 this Tuesday February 10th, decreasing 2.88 or 1.70 percent since the previous trading session. Looking back, over the last four weeks, Zhangzhou Pientzehuang Pharmaceutical lost 4.08 percent. Over the last 12 months, its price fell by 19.69 percent. Looking ahead, we forecast Zhangzhou Pientzehuang Pharmaceutical Co Ltd to be priced at 166.29 by the end of this quarter and at 155.65 in one year, according to Trading Economics global macro models projections and analysts expectations.

Zhangzhou Pientzehuang Pharmaceutical Co Ltd is a China-based company mainly engaged in drug production and sales. The Company is also engaged in the production and sales of cosmetics and daily chemical products and the circulation of medicine. The Company''s core products are PianZi Huang series products, including PianZi Huang, PianZi Huang capsule, compound PianZi Huang buccal tablets, compound PianZi Huang ointment, compound PianZi Huang hemorrhoids ointment and others, covering many fields such as liver disease medication, cold medication, dermatology medication. The Company''s products are sold to domestic and overseas markets.